As we enter the era of agentic AI, here's how organizations can treat this innovation as an operating paradigm.

Alembic Technologies, a pioneer in Causal AI for the enterprise, today announced it has secured $145 million in Series B and growth funding — a 15.7x increase in valuation over their Series A round.

NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive ...

As traditional SEO practices become increasingly outdated, SEOengine.ai is leading the charge in adapting businesses’ content strategies to an AI-first search landscape. With its ability to scale ...